Salīdzināt metodes

	Anketas "Matu izkrišanas ietekmes novērtējums" (ALPPQ)	POEM (Pacientu novērtējuma ekzēmas skala)
Nozare	Dermatoloģija	Dermatoloģija
Saime	Process / pipeline	Process / pipeline
Izcelsmes gads	2014	2004
Autors	Gupta AK, Strober BE et al.	Charman CR, Venn AJ, Williams HC
Tips	Self-report	Self-report
Pirmavots	Gupta AK, Talukder M. Alopecia areata: autoimmune basis of hair loss and available treatment options. Can J Dermatol. 2014;12(5):289-304.	Charman CR, Venn AJ, Williams HC. The Patient-Oriented Eczema Measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol. 2004;140(12):1513-1519.
Citi nosaukumi	Hair Loss Impact Questionnaire, Alopecia Areata QoL	POEM Score
Saistītās	4	2
Kopsavilkums	The Hair Loss Impact Questionnaire (Alopecia Areata Patient Priority Outcomes Questionnaire, ALPPQ) is a disease-specific, patient-administered quality-of-life measure assessing the psychosocial and functional burden of alopecia areata, a chronic autoimmune disorder causing patchy hair loss. Alopecia areata affects appearance, self-esteem, and social functioning disproportionately, often causing depression and anxiety. The ALPPQ captures these impacts, ensuring that treatment efficacy encompasses meaningful quality-of-life outcomes. It is increasingly used in clinical trials and observational studies of alopecia areata therapeutics.	The POEM is a brief, patient-administered severity measure for atopic dermatitis that focuses on frequency of symptoms experienced over the past week. Developed by Charman, Venn, and Williams in 2004, it emphasizes the patient's lived experience rather than clinician observation, making it practical for routine clinical practice and remote monitoring. POEM is increasingly used alongside objective measures in clinical trials and outpatient care.